If you’ve got a seat at the Palantir table, congratulations. You’re enjoying the ride. If you haven’t bought in yet, though, you might want to mark a certain date on your calendar – Nov. 3. A date that could either send Palantir’s stock soaring or crash it into oblivion. Should you pile in now or wait for the inevitable freakshow to unfold? Let’s take a deep breath and find out.
I think management’s Q3 outlook could be another catalyst. Buying before Oct. 29 feels like betting on a horse that’s already sprinting. But let’s not pretend I’m not curious to see if the party keeps going.
If Nvidia were a character in a Dickens novel, it would be Ebenezer Scrooge-except instead of hoarding gold, it’s gobbling up market share. Last fiscal year, sales jumped 114% to $130.5 billion, a figure so staggering it could make even Warren Buffett raise an eyebrow. And the momentum shows no sign of slowing: First-half revenue for 2026 already sits at $90.8 billion, up from $56.1 billion the year before. Operating income? A gaudy $50.1 billion, up over 40%. It’s like watching a steamroller roll over a bag of cash.
Let’s start with a couple of ETFs on the equity side of things that should be your bread and butter: the Schwab U.S. Dividend Equity ETF (SCHD) and the Vanguard Dividend Appreciation ETF (VIG). And for a dash of stability, we’ll sprinkle in a trusty bond ETF – the Vanguard Intermediate-Term Bond ETF (BIV). They’re all different flavors of income generation, and together, they form a portfolio that’s not only diverse but also remarkably resilient.
On Nov. 6, the curtain lifts for Q3 2025 earnings-a report that could either validate this speculative fever or send shareholders scrambling. Let’s dissect this peculiar beast with the caution of someone poking a beehive with a stick.
SoFi’s financials gleam, yes-revenue surging, customers multiplying like dandelions in a breeze. Yet the market, that fickle observer, has begun to paint the company in hues of optimism, as though it were a fresco newly unveiled. But what is optimism but the sunlit face of uncertainty?
Two titans currently reign over this realm of subcutaneous salvation: their syringes glisten like Excalibur in the pharmaceutical armory. Yet lo! A third act approaches, wherein oral formulations-those convenient little sacraments of compliance-threaten to upend the order of things. Let us now wander this gallery of grotesque ambition, where vanity battles biology with prescriptions as weapons.
Four noble (or rather, delusional) stocks-IonQ, Rigetti Computing, D-Wave Quantum, and Quantum Computing, Inc.-have ascended with such velocity that one might mistake them for comets. Their trailing-12-month gains? A 570%, 6,590%, 4,340%, and 2,830% respectively. A veritable danse macabre of exuberance!
The equity performance of Nvidia (NVDA) and Palantir Technologies (PLTR) exemplifies both the opportunities and risks inherent in AI-driven growth. Since 2022, Nvidia’s shares have appreciated 1,100%, while Palantir’s have surged 2,700%. However, these gains coincide with significant insider selling activity that warrants scrutiny.
In the autumn of 2020, when the world teetered on the edge of reason and madness, Shiba Inu emerged-a digital Cerberus with three tails, each wagging to the rhythm of TikTok trends. Its price, then a decimal so minuscule it might have been mistaken for a typo, ballooned into the celestial spheres by 2021. Let us dissect this leviathan: a $500 stake in October 2020 would today purchase a palace in Monaco, assuming palaces were priced at $50 million and Monaco had not yet succumbed to the sea.